Assessing the scientific soundness of a project before it consumes time and money: launching an innovative concept, funding an R&D program, an acquisition, or regulatory validation.
You get: a reasoned opinion, a due diligence report or a prioritized roadmap.
1–3 / 6
Scientific and clinical due diligenceIndependent assessment of an asset, a technology, a health innovation or a start-up ahead of an investment, acquisition or partnership: strength of the data, risks, key questions.
Assessment of innovative conceptsReview of the scientific rationale behind an ingredient, a product, a technology or a digital solution: mechanisms of action, state of the art, potential applications.
Program review and development planMaturity assessment of an R&D program, identification of evidence gaps, then definition of the studies, milestones and decision criteria.
B · Preclinical and clinical research
Demonstrate
Designing and running the studies that test your hypotheses, from mechanism of action to proof in humans, with the right balance between regulatory requirements, scientific and commercial objectives, budget and timelines, without compromising scientific quality.
You get: a submission-ready protocol, selected vendors and a study managed through to the final report.
1–3 / 6
Clinical strategy and study designObjectives, population, design, dose, duration and feasibility: from rationale to a submission-ready protocol.
Operational management and oversight of external vendorsEnd-to-end clinical study oversight on the sponsor side: governance, monitoring plans, tracking of recruitment, budget, timelines and quality, with the CRO, investigator sites and every vendor: analytical labs, clinical batch manufacturing and logistics, data management, biostatistics.
Partner and vendor selectionTenders, comparison and selection of the CROs, labs, investigator sites, universities and experts best suited to the project.
C · Interpretation and scientific communication
Communicate
Turning data into usable results, then adapting them to each purpose: scientific, regulatory and commercial.
You get: interpreted, usable results: a publication, a regulatory dossier or a scientific argument.
1–3 / 6
Interpreting resultsClinical reading of the data and exploratory statistical analyses, to separate what is proven, what can be claimed and what still needs confirming.
Publications and conferencesArticles for peer-reviewed journals, abstracts, posters and presentations.
Reports and regulatory dossiersClinical study reports (CSRs) and the scientific sections of health claim, marketing authorization or reimbursement dossiers, aligned with EMA, FDA, EFSA and HTA expectations.
How I work
A few days or several months, full-time or part-time: the format adapts to your project, your teams and your timeline — to absorb a peak in activity or strengthen an R&D team.
1ScopingOne or more meetings to get to know each other and clarify your needs. A confidentiality agreement from the start, then a detailed proposal.
2ProposalContractual terms: scope, deliverables, timeline and budget, refined together.
3DeliveryRegular check-ins, documents shared as we go, weekly or monthly reporting as needed.
4HandoverFinal deliverables, adjustments, close-out, and a discussion of possible next steps.
How I work
A few days or several months, full-time or part-time: the format adapts to your project, your teams and your timeline — to absorb a peak in activity or strengthen an R&D team.